This site is intended for healthcare professionals

Medical education
Specialty
News
Congresses

Search
Menu

Home
Medical education
Specialty
News
Congresses

Close up of a deep blue camera lens

Home
/
Medical education
/
Psoriasis Academy – Overview
/
Psoriasis treatment videos
/
Benefits of inhibiting IL-23p19 compared to IL-12 ...

Benefits of inhibiting IL-23p19 compared to IL-12 or IL-23 in moderate-to-severe psoriasis

Psoriasis Academy – Overview

The Academy
Patient-centred care in psoriasis
Psoriasis Management
Psoriasis Treatment
Key evidence on psoriasis treatments
Psoriasis Guidelines
Expert opinion – patient wellbeing in psoriasis
Feedback

Benefits of inhibiting IL-23p19 compared to IL-12 or IL-23 in moderate-to-severe psoriasis

Get closer to the conversations that matter in medicine

ABOUT US
MEDICAL EDUCATION
SPECIALTIES
CONGRESS & EVENTS
NEWS & INSIGHTS
FOR GRANT PROVIDERS

© Medthority 2025 | Medthority.com

Privacy policy
Contact us